INCUCYTE SX5 HD/3CLR SYS PKG
ID: NOI-NIAID-25-2250315Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

Original Source

https://sam.gov/opp/c178ef2df15146d39813c2fc083827ea/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to procure the Incucyte SX5 HD/3CLR System Package from Sartorius Corporation through a sole source contract. The procurement aims to acquire advanced live-cell imaging and analysis capabilities, which are critical for long-term time-lapse experiments and precise cell observation in various cell biology research applications. Interested vendors must submit a capability statement addressing specific technical requirements by 10:00 AM EST on December 19, 2024, via the NIAID electronic Simplified Acquisition Submission System (eSASS). For further inquiries, vendors can contact Rubyanne Matthews at rubyanne.matthews@nih.gov or Jesse Weidow at jesse.weidow@NIH.gov.

    Point(s) of Contact
    Rubyanne Matthewss
    rubyanne.matthews@nih.gov
    Jesse Weidow
    jesse.weidow@NIH.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    INCUCYTE SX5 HD/3CLR SYS PKG
    Currently viewing
    Sources Sought
    Similar Opportunities
    Opera Phenix Plus High-Content Screening System (or equal)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide an Opera Phenix Plus High-Content Screening System or an equivalent product for the Intramural Center for Alzheimer’s and Related Dementias (CARD). The procurement aims to acquire a high-content imaging system capable of analyzing cellular samples, including organoids and tissue slices, to support research on neurodegenerative diseases. This initiative is critical for advancing the understanding of Alzheimer’s disease and related conditions through the analysis of induced pluripotent stem cells (iPSCs). Interested vendors must submit their capability statements by December 27, 2024, at 5 PM Eastern Time, to Iris Merscher at iris.merscher@nih.gov, ensuring compliance with the specified requirements and guidelines.
    CHROMIUM IX/X AND VISIUM CYTASSIT ASSURANCE PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a sole-source contract with 10X Genomics, Inc. for a warranty and maintenance agreement for their Chromium X and CytAssist instruments. This procurement is critical as these instruments are essential for conducting advanced single-cell sequencing and spatial transcriptomics research, which supports the development of new diagnostics, therapeutics, and vaccines against human diseases. The maintenance agreement will ensure uninterrupted operation of these technologies, which are vital for NIAID researchers, and interested vendors must submit their capabilities statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on December 30, 2024. For further inquiries, vendors can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D. Weidow at weidowjd@niaid.nih.gov.
    In Vitro Biological Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source procurement with Becton, Dickinson and Company for various in vitro biological reagents essential for research purposes. The procurement includes specific quantities of antibodies and reagents, such as Hu CD183 BV711 and Hu IL-13 BV421, along with shipping and handling to be delivered to Gaithersburg, Maryland. This procurement is justified under the authority of 41 U.S.C. 1901 (a)(1), indicating that only one responsible source can meet the agency's requirements. Interested parties may submit a capability statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 30, 2024, with all submissions considered at the Government's discretion. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.
    Cytiva Sefia S-2000 Cell Processing Instrument Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source contract to Global Life Sciences Solutions USA LLC for preventative maintenance services on three Cytiva Sefia S-2000 Cell Processing Instruments located at the NIH Clinical Center in Bethesda, Maryland. The contract will cover unlimited service repair and preventive maintenance for these critical instruments used in cell therapy manufacturing and research, which are essential for compliance with FDA regulations regarding the maintenance of equipment used in drug product manufacturing. Interested parties capable of providing similar services may submit a capability statement by December 29, 2024, at 12:00 pm EST to Sheri Eiri at sheri.eiri@nih.gov for consideration in the procurement process.
    Orbitor RS2 Microplate Robotic Bundle with Software
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through its National Institute of Allergy and Infectious Diseases (NIAID), intends to procure an Orbitor RS2 Microplate Robotic Bundle with integrated software for its Vaccine Immunology Program (VIP) within the Vaccine Research Center (VRC). This procurement aims to automate the handling and analysis of Mabtech Fluorospot Assays, which are critical for evaluating T-cell responses in clinical trials, thereby enhancing the efficiency and accuracy of vaccine research. The equipment must meet specific technical requirements, including compatibility with existing lab systems and advanced features such as a bi-directional telescoping arm and Momentum™ scheduling software. Interested vendors are invited to submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by January 3, 2025, at 5:00 PM ET, with all submissions considered by the Government at its discretion.
    NOTICE OF INTENT TO SOLE SOURCE: Preventative Maintenance Services for Nikon CSU-W1 SoRa Spinning Disk Microscope
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), through its National Cancer Institute (NCI), intends to procure sole source preventative maintenance services for a government-owned Nikon CSU-W1 SoRa Spinning Disk Microscope, which is critical for imaging work at the NCI's Laboratory of Cancer Biology and Genetics. The procurement requires comprehensive maintenance services, including routine inspections, emergency repairs, and software updates, all performed by OEM-trained technicians to ensure compliance with manufacturer specifications and uninterrupted operation of this essential research equipment. Interested vendors must submit capability statements by December 30, 2024, and must be registered in the System for Award Management (SAM) to be considered for this firm fixed-price contract, which includes a 12-month base period and four option periods. For further inquiries, vendors can contact Lena Lee, Contract Specialist, at lena.lee@nih.gov.
    Global Life Sciences Solutions Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract for preventative maintenance services for three Sepax Pro Cell Processing Systems used in cell therapy manufacturing and research. The contract will be awarded to Global Life Sciences Solutions USA LLC, the only vendor authorized to perform these services due to the proprietary nature of the equipment and the requirement for compliance with FDA regulations regarding critical equipment maintenance. The period of performance for this contract is set from January 27, 2025, to January 26, 2026, with interested parties encouraged to submit capability statements by December 28, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.
    Imaris 10.2 for Neuroscientists (FL)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (NINDS), intends to award a sole-source contract for the acquisition of IMARIS 10.2 software, which is crucial for enhancing cellular analysis capabilities in ongoing neurological research. This specialized software, provided by Oxford Instruments Andor Technology Inc., is designed for advanced 3D and 4D microscopy image analysis, offering unique features such as advanced image segmentation and quantitative analysis tools essential for studying complex cellular interactions in glioma research. The contract is expected to be awarded on a firm-fixed price basis, with delivery anticipated within 14 days post-award. Interested parties may submit capability statements to Shayna Simpson at shayna.simpson@nih.gov by the specified deadline, although the procurement is not open for competitive proposals due to the exclusive nature of the software.
    NOTICE OF INTENT TO SOLE SOURCE: Preventative Maintenance Service for Zeiss Confocal and Epifluorescence Microscopes
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), intends to procure preventative maintenance and emergency services for fourteen government-owned Zeiss microscopes, which are critical for cancer research conducted by the Laboratory of Cancer Biology and Genetics. The procurement will be conducted on a sole-source basis with Carl Zeiss Microscopy, LLC, the original equipment manufacturer, due to its proprietary software and the necessity for authorized service technicians to ensure compliance with manufacturer specifications. This maintenance contract is vital for maintaining the operational functionality of the microscopes, which play a significant role in biological specimen analysis. Interested parties, particularly small businesses, are invited to submit capability statements by January 6, 2025, to be considered for potential competitive procurement. For further inquiries, contact Lena Lee at lena.lee@nih.gov.
    Ongoing Monoclonal Antibodies and Plasmids Services through GENSCRIPT
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with GenScript USA Inc. for ongoing monoclonal antibodies and plasmids services. The procurement aims to support the NIAID Laboratory of Immunogenetics (LIG) in advancing research on human B cells and the isolation of monoclonal antibodies, which are critical for developing new vaccine candidates against influenza. This contract is a continuation of existing services that require continuity for accurate comparison of results, and interested parties may submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by January 3, 2025, at 5:00 PM ET. For further inquiries, contact Dana Monroe at dana.monroe@nih.gov or call 406-375-9814.